Opportunity Information: Apply for SOL OAA 13 000024
Apply for SOL OAA 13 000024
- The Agency for International Development in the health sector is offering a public funding opportunity titled "Family Planning and Reproductive Health Methods APS" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
- This funding opportunity was created on Jan 16, 2015 and posted on Jan 15, 2013.
- Applicants must submit their applications by Jan 14, 2023. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $80,000,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible organizations include registered U.S. and non U.S. private non governmental organizations, non profit organizations and for profit organizations willing to forego profit.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
USAID's Family Planning and Reproductive Health Methods APS (Funding Opportunity Number SOL-OAA-13-000024) is a discretionary funding opportunity that uses cooperative agreements to support research, development, and practical introduction of family planning and reproductive health technologies. The core idea is to help create and improve contraceptive and reproductive health options that better match real-world needs of women and girls as those needs shift across life stages, relationships, and health circumstances. Rather than focusing only on availability of services, the APS is aimed at the methods themselves and the approaches needed to make those methods acceptable, reliable, and usable in routine settings.
The APS lays out several major technical objectives. One priority is refining existing family planning methods to reduce method-related reasons people choose not to use them, which can include side effects, ease of use, comfort, discretion, dosing schedules, or other features that shape satisfaction and continuation. Another priority is responding to product-related issues that emerge either during procurement or once products are in the field, especially issues that can affect provider and user confidence or disrupt the supply chain. This can include concerns around packaging, storage, shelf life, product quality, user instructions, and any performance or perception problems that could reduce uptake even when a method is otherwise clinically effective.
In addition to improving what already exists, the APS explicitly supports development of new family planning methods that either address method-related barriers to use or fill gaps in the current method mix. The emphasis on gaps signals interest in expanding options beyond what is commonly available, particularly by offering additional choices that women can initiate and control. Closely related to this, the APS supports research to improve the introduction and uptake of new or underutilized woman-initiated methods. It highlights non-hormonal barrier methods, contraceptive vaginal rings, and fertility awareness methods that rely on knowledge and monitoring of the menstrual cycle, indicating interest not just in product development but also in the evidence, implementation strategies, and user-centered research needed for successful adoption.
A fifth major objective is the development of multipurpose prevention technologies (MPTs). These are products designed to address multiple sexual and reproductive health risks at the same time, specifically unintended pregnancy and prevention of HIV and other sexually transmitted infections. The APS calls out herpes simplex virus (HSV) and human papillomavirus (HPV) in particular, pointing to a combined prevention agenda where one technology may offer contraception plus protection against one or more infections, which can be especially valuable in settings where people face overlapping risks and where a single, easy-to-use product could improve consistent use.
From an applicant and administrative perspective, the opportunity is offered by the U.S. Agency for International Development under CFDA 98.001 (USAID Foreign Assistance for Programs Overseas). The instrument type is a cooperative agreement, which generally means USAID expects substantial involvement during implementation, such as collaboration on technical direction, oversight, and coordination. The posting date listed is January 15, 2013, with an original and current closing date of January 14, 2023. The award size ranges from a floor of $500,000 to a ceiling of $80,000,000, suggesting support for both moderate projects and large, multi-year efforts depending on scope and program design. Cost sharing or matching is required, so applicants are expected to contribute resources or secure partner contributions as part of the overall project financing plan.
Eligibility is broad but focused on organizational capacity. Eligible entities include registered U.S. and non-U.S. private non-governmental organizations, non-profit organizations, and for-profit organizations that are willing to forego profit under the award. While the summary notes USAID is seeking concept papers from qualified U.S. non-profit NGOs, the eligibility language indicates that non-U.S. NGOs and certain for-profit entities may also be considered if they meet the conditions stated in the announcement. The opportunity also provides a point of contact for access issues with the full announcement: Jacquelin Bell, Agreement Specialist, via the listed email address.
Frequently Asked Questions (FAQs): USAID Family Planning and Reproductive Health Methods APS (SOL-OAA-13-000024)
What is this funding opportunity?
This opportunity is USAID's Family Planning and Reproductive Health Methods Annual Program Statement (APS), Funding Opportunity Number SOL-OAA-13-000024. It is a discretionary funding opportunity that uses cooperative agreements to support research, development, and practical introduction of family planning and reproductive health technologies.
What is the main purpose of the APS?
The APS is designed to help create and improve contraceptive and reproductive health options that better match real-world needs of women and girls as those needs change across life stages, relationships, and health circumstances. It focuses on the methods themselves and the approaches needed to make those methods acceptable, reliable, and usable in routine settings.
Does this APS focus on service delivery or on the methods/technologies?
The APS is aimed primarily at the methods and technologies (and how they are made acceptable and usable), rather than focusing only on the availability of services.
What type of award instrument will USAID use?
USAID plans to use a cooperative agreement.
What does "cooperative agreement" imply for implementation?
A cooperative agreement generally means USAID expects substantial involvement during implementation, such as collaboration on technical direction, oversight, and coordination.
What are the major technical objectives described in the APS?
The APS describes multiple technical objectives, including: refining existing family planning methods; addressing product-related issues that arise during procurement or field use; developing new family planning methods to overcome barriers or fill gaps in the method mix; improving the introduction and uptake of new or underutilized woman-initiated methods; and developing multipurpose prevention technologies (MPTs) that address unintended pregnancy and prevention of HIV and other sexually transmitted infections.
What does the APS mean by refining existing methods?
Refining existing methods refers to improving current family planning options to reduce method-related reasons people choose not to use them. Examples of features that may be improved include side effects, ease of use, comfort, discretion, dosing schedules, or other factors that influence satisfaction and continuation.
What kinds of product-related issues are in scope?
The APS includes addressing product-related issues that emerge during procurement or once products are in the field, particularly issues that can reduce provider and user confidence or disrupt the supply chain.
Can projects address packaging, storage, or shelf life concerns?
Yes. The APS specifically notes issues such as packaging, storage, shelf life, product quality, user instructions, and performance or perception problems that could reduce uptake even when a method is clinically effective.
Does the APS support development of entirely new family planning methods?
Yes. The APS explicitly supports development of new family planning methods that address method-related barriers to use or fill gaps in the current method mix.
What does "gaps in the current method mix" imply?
It signals interest in expanding options beyond what is commonly available, with particular interest in additional choices that women can initiate and control.
Does the APS support research on introducing and increasing uptake of methods?
Yes. The APS supports research to improve the introduction and uptake of new or underutilized woman-initiated methods, emphasizing not only product development but also the evidence, implementation strategies, and user-centered research needed for successful adoption.
Which woman-initiated methods are specifically highlighted?
The APS highlights non-hormonal barrier methods, contraceptive vaginal rings, and fertility awareness methods that rely on knowledge and monitoring of the menstrual cycle.
What are multipurpose prevention technologies (MPTs) in this APS?
MPTs are products designed to address multiple sexual and reproductive health risks at the same time, specifically unintended pregnancy and prevention of HIV and other sexually transmitted infections.
Which sexually transmitted infections are specifically called out for MPT work?
The APS calls out herpes simplex virus (HSV) and human papillomavirus (HPV) in particular, alongside prevention of HIV and other sexually transmitted infections.
What is the CFDA number associated with this opportunity?
The opportunity is offered under CFDA 98.001, USAID Foreign Assistance for Programs Overseas.
When was this opportunity posted and what is the closing date?
The posting date listed is January 15, 2013. The original and current closing date listed is January 14, 2023.
What is the expected award size range?
The award size ranges from a floor of $500,000 to a ceiling of $80,000,000, indicating the opportunity can support both moderate projects and large, multi-year efforts depending on scope and program design.
Is cost sharing or matching required?
Yes. Cost sharing or matching is required, meaning applicants are expected to contribute resources or secure partner contributions as part of the overall financing plan.
Who is eligible to apply?
Eligibility includes registered U.S. and non-U.S. private non-governmental organizations, non-profit organizations, and for-profit organizations that are willing to forego profit under the award.
Are for-profit organizations allowed to apply?
Yes, for-profit organizations may be eligible if they are willing to forego profit under the award, as stated in the eligibility language.
Are non-U.S. organizations eligible?
Yes. The eligibility language includes registered non-U.S. private NGOs, though the summary also notes USAID is seeking concept papers from qualified U.S. non-profit NGOs.
Is USAID requesting concept papers?
Yes. The summary notes USAID is seeking concept papers from qualified U.S. non-profit NGOs, while broader eligibility language indicates additional organization types may also be considered if they meet the stated conditions.
Who should be contacted for access issues with the full announcement?
For access issues with the full announcement, the listed point of contact is Jacquelin Bell, Agreement Specialist, via the email address provided in the announcement.
Browse more opportunities from the same agency: Agency for International Development
Browse more opportunities from the same category: Health
Next opportunity: NIST Standards Services Curricula Development Cooperative Agreement Program
Previous opportunity: FOA Algae Biofuel Yield (ABY)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for SOL OAA 13 000024
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (SOL OAA 13 000024) also looked into and applied for these:
| Funding Opportunity |
|---|
| Statewide Consumer Network Grant Apply for SM 13 004 Funding Number: SM 13 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Implementing Public Health Programs and Strengthening Public Health Capacity in Guatemala and Central American Apply for CDC RFA GH13 1306 Funding Number: CDC RFA GH13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Engaging Parents in Prevention of Child Sexual Abuse and Sexual Risk Behaviors Targeting Youth Scaling up the Implementation of Families Matter in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1324 Funding Number: CDC RFA GH13 1324 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Clinical Neuroscience and Entertainment Software Pilot Partnership Program to Develop Neuropsychiatric Interventions (R43/R44) Apply for RFA MH 14 010 Funding Number: RFA MH 14 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Revisions for DNA Collection from Existing Longitudinal Aging Cohorts in Africa (R01) Apply for RFA AG 13 018 Funding Number: RFA AG 13 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMHD Minority Health and Health Disparities International Research Training (T37) Apply for RFA MD 13 002 Funding Number: RFA MD 13 002 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Biodynamics Grant Opportunity Apply for 13 01 Funding Number: 13 01 Agency: DOT FAA Aviation Research Grants Category: Health Funding Amount: $750,000 |
| Small Rural Hospital Improvement Grant Program (SHIP) Apply for HRSA 13 163 Funding Number: HRSA 13 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: $9,000 |
| New Access Point Grants Apply for HRSA 13 228 Funding Number: HRSA 13 228 Agency: Health Resources and Services Administration Category: Health Funding Amount: $650,000 |
| Saving Lives at Birth A Grand Challenge for Development (Round 3) Apply for RFA OAA 13 000004 Funding Number: RFA OAA 13 000004 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Strengthen Brazils National Response to HIV and other diseases through innovative and evidence based approaches in laboratory, strategic information, prevention and care activities and foster partnerships between Brazil, Angola and Mozambique (PEPFAR Apply for CDC RFA GH13 1343 Funding Number: CDC RFA GH13 1343 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Tanzanian Ministry of Health and Social Welfare System Strengthening for Enhanced Evidence Based Decision Making and Management and Delivery of Quality Health Services in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Re Apply for CDC RFA GH13 1319 Funding Number: CDC RFA GH13 1319 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Rural Training Track Technical Assistance Demonstration Program Apply for HRSA 13 247 Funding Number: HRSA 13 247 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Modification 1 Questions and Answer to the APS Apply for APS 442 13 000001 Funding Number: APS 442 13 000001 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $100,000 |
| Drug Free Communities (DFC) Support Program Apply for SP 13 002 Funding Number: SP 13 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Support for Community Vital Registration in the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1349 Funding Number: CDC RFA GH13 1349 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| HIV care and treatment services in the Dukwi refugee camp in Botswana under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1355 Funding Number: CDC RFA GH13 1355 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| The Namibian Mechanism for Public Health and Medical Education (NAM PHAME) under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1358 Funding Number: CDC RFA GH13 1358 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Improving the Quality of Namibias Essential Health Apply for CDC RFA GH13 1359 Funding Number: CDC RFA GH13 1359 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $23,000,000 |
| Delta States Rural Development Network Grant Program Apply for HRSA 13 157 Funding Number: HRSA 13 157 Agency: Health Resources and Services Administration Category: Health Funding Amount: $25,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "SOL OAA 13 000024", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.